Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
Duloxetine treatment for women with premenstrual dysphoric disorder: a single-blind trial
International Journal of Neuropsychopharmacology, 08/17/09
Ramos MG et al. – Significant improvements were demonstrated by secondary measures, including reduction in self–rated functional impairment and improvement in quality of life. The main side–effects associated with duloxetine were dry mouth, nausea, drowsiness, insomnia, decreased appetite, decreased libido, and sweating. Duloxetine was effective and generally well tolerated in the treatment of PMDD.
Related Articles
The association between arthritis and psychiatric disorders; results from a longitudinal population-based study
Journal of Psychosomatic Research, 10/12/09
Relevance Score: 47%
Clinical management of motility disorders in children
Seminars in Pediatric Surgery, 10/01/09
Relevance Score: 47%
Comorbidity in Adults With Attention-Deficit Hyperactivity Disorder
Canadian Journal of Psychiatry, 10/20/09
Relevance Score: 46%
Do mental disorders and eating patterns affect long-term weight loss maintenance
General Hospital Psychiatry, 10/19/09
Relevance Score: 46%
Obsessive-compulsive spectrum and disorders of the skin
Expert Review of Dermatology, 10/14/09
Relevance Score: 46%
Today in Drug Trials...keeping you current
Receive free subspecialty "5-minute updates" via email
Novartis Tasigna trial shows superior results to Glivec in patients with early-stage chronic myeloid leukemia
Novartis, 12/09/09
Umbilical vein oxytocin for the treatment of retained placenta (Release Study): a double-blind, randomised controlled trial
The Lancet - Early Online Publication, 12/08/09
Autologous blood therapy for common cold—A randomized, double-blind, placebo-controlled trial
Complementary Therapies in Medicine, 12/08/09
Today in Neuro/Psych pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Combination of intensive cognitive rehabilitation and donepezil therapy in Alzheimer's disease (AD)
Archives of Gerontology and Geriatrics, 12/09/09
Chronic treatment with Escitalopram, but not R-citalopram translocates G?s from lipid raft domains and potentiates adenylyl cyclase: A 5-HT transporter independent action of this antidepressant compound
Journal of Pharmacology and Experimental Therapeutics, 12/09/09
Thiazolidinediones and the risk of incident strokes in patients with type 2 diabetes
Pharmacoepidemiology and Drug Safety, 12/09/09
Today in Other Drugs...keeping you current
Receive free subspecialty "5-minute updates" via email
Sulfhydryl angiotensin converting enzyme inhibitor promotes endothelial cell survival through nitric oxide synthase, fibroblast growth factor-2 and telomerase cross-talk
Journal of Pharmacology and Experimental Therapeutics, 12/09/09
Thiazolidinediones and the risk of incident strokes in patients with type 2 diabetes
Pharmacoepidemiology and Drug Safety, 12/09/09
Oxybutynin chloride topical gel: a new formulation of an established antimuscarinic therapy for overactive bladder
Expert Opinion in Pharmacotherapy, 12/09/09
Sponsor
Article Search
Sponsor


See Latest Articles


